Knadler MP - Search Results

1

Hepatic effects of duloxetine-I: non-clinical and clinical trial data.

Wernicke J, Pangallo B, Wang F, Murray I, Henck JW, Knadler MP, D'Souza DN, Uetrecht JP. Wernicke J, et al. Among authors: knadler mp. Curr Drug Saf. 2008 May;3(2):132-42. doi: 10.2174/157488608784529189. Curr Drug Saf. 2008. PMID: 18690991 Review.

2

Effects of duloxetine on norepinephrine and serotonin transporter activity in healthy subjects.

Chappell JC, Eisenhofer G, Owens MJ, Haber H, Lachno DR, Dean RA, Knadler MP, Nemeroff CB, Mitchell MI, Detke MJ, Iyengar S, Pangallo B, Lobo ED. Chappell JC, et al. Among authors: knadler mp. J Clin Psychopharmacol. 2014 Feb;34(1):9-16. doi: 10.1097/JCP.0000000000000061. J Clin Psychopharmacol. 2014. PMID: 24346757 Clinical Trial.

3

The dual transporter inhibitor duloxetine: a review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression.

Bymaster FP, Lee TC, Knadler MP, Detke MJ, Iyengar S. Bymaster FP, et al. Among authors: knadler mp. Curr Pharm Des. 2005;11(12):1475-93. doi: 10.2174/1381612053764805. Curr Pharm Des. 2005. PMID: 15892657 Review.

4

Duloxetine: clinical pharmacokinetics and drug interactions.

Knadler MP, Lobo E, Chappell J, Bergstrom R. Knadler MP, et al. Clin Pharmacokinet. 2011 May;50(5):281-94. doi: 10.2165/11539240-000000000-00000. Clin Pharmacokinet. 2011. PMID: 21366359 Review.

5

Effect of age on the pharmacokinetics of duloxetine in women.

Skinner MH, Kuan HY, Skerjanec A, Seger ME, Heathman M, O'Brien L, Reddy S, Knadler MP. Skinner MH, et al. Among authors: knadler mp. Br J Clin Pharmacol. 2004 Jan;57(1):54-61. doi: 10.1046/j.1365-2125.2003.01963.x. Br J Clin Pharmacol. 2004. PMID: 14678340 Free PMC article. Clinical Trial.

6

In vitro and in vivo evaluations of cytochrome P450 1A2 interactions with duloxetine.

Lobo ED, Bergstrom RF, Reddy S, Quinlan T, Chappell J, Hong Q, Ring B, Knadler MP. Lobo ED, et al. Among authors: knadler mp. Clin Pharmacokinet. 2008;47(3):191-202. doi: 10.2165/00003088-200847030-00005. Clin Pharmacokinet. 2008. PMID: 18307373 Clinical Trial.

7

Effects of duloxetine on the pharmacodynamics and pharmacokinetics of warfarin at steady state in healthy subjects.

Chappell J, He J, Knadler MP, Mitchell M, Lee D, Lobo E. Chappell J, et al. Among authors: knadler mp. J Clin Pharmacol. 2009 Dec;49(12):1456-66. doi: 10.1177/0091270009344335. Epub 2009 Sep 30. J Clin Pharmacol. 2009. PMID: 19793910 Clinical Trial.

8

Duloxetine pharmacokinetics in cirrhotics compared with healthy subjects.

Suri A, Reddy S, Gonzales C, Knadler MP, Branch RA, Skinner MH. Suri A, et al. Among authors: knadler mp. Int J Clin Pharmacol Ther. 2005 Feb;43(2):78-84. doi: 10.5414/cpp43078. Int J Clin Pharmacol Ther. 2005. PMID: 15726876 Clinical Trial.

9

Population pharmacokinetics of orally administered duloxetine in patients: implications for dosing recommendation.

Lobo ED, Quinlan T, O'Brien L, Knadler MP, Heathman M. Lobo ED, et al. Among authors: knadler mp. Clin Pharmacokinet. 2009;48(3):189-97. doi: 10.2165/00003088-200948030-00005. Clin Pharmacokinet. 2009. PMID: 19385712

10

Pharmacokinetics of duloxetine in breast milk and plasma of healthy postpartum women.

Lobo ED, Loghin C, Knadler MP, Quinlan T, Zhang L, Chappell J, Lucas R, Bergstrom RF. Lobo ED, et al. Among authors: knadler mp. Clin Pharmacokinet. 2008;47(2):103-9. doi: 10.2165/00003088-200847020-00003. Clin Pharmacokinet. 2008. PMID: 18193916 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters